Animal study, human observational, RCT — these terms are frequently misused in biohacking communities. A practical guide to evaluating peptide evidence quality before drawing conclusions. Historical articles may no longer reflect current regulatory status. Check the cited primary source.
The most consequential mistake in peptide research communities is conflating evidence tiers. "There are studies on this" is treated as equivalent to "this has been proven in humans." It is not. The four evidence tiers used by PeptideX represent fundamentally different levels of confidence — and the differences matter.
Human RCT (Score ceiling: 5/5)
We email you when the FDA or HHS makes a move on a peptide you care about. Every email links the official source. No spam, no sales.
We don't collect health information. Unsubscribe anytime. Privacy policy
A randomized controlled trial with human subjects, control group, and pre-registered endpoint. This is the standard required for FDA approval. Examples in the PeptideX index: Semaglutide (multiple RCTs, 5/5), Thymosin Alpha-1 (11 RCTs, 4/5), NAD+ precursors (multiple RCTs, 4/5). The presence of an RCT does not guarantee benefit — it guarantees that an appropriately designed test was conducted.
Human Observational (Score ceiling: 4/5)
Human subjects were studied, but without randomization, control, or pre-registered endpoints. Case series, cohort studies, cross-sectional analyses. Examples: Epithalon (small Russian observational studies, 3/5), Selank (Russian clinical series, 3/5). Observational data can generate hypotheses. It cannot establish causation.
Animal Only (Score ceiling: 3/5)
All evidence from rodent or other preclinical models. This is the majority of the peptide space. Examples: BPC-157 (544 PubMed citations, almost entirely rodent, 2/5), MOTS-c (strong mouse data, 2/5). Animal models fail to translate to human outcomes at a high rate — particularly in aging and neurology research. A compelling animal study is a research signal, not a clinical recommendation.
Theoretical (Score ceiling: 2/5)
A proposed mechanism with no controlled experimental validation. Examples: Several novel peptides in the PeptideX index. The mechanism sounds plausible. No one has tested it in a controlled setting.
When a community member says "BPC-157 healed my tendon injury," that is an anecdote, not evidence. When a vendor says "shown to promote tissue repair," that may accurately describe animal data while implying human efficacy. When a practitioner prescribes based on forum consensus rather than evidence tier, they are making a decision with Animal Only confidence as if it were Human RCT confidence.
The PeptideX evidence tier is displayed prominently on every compound page. It is the most important single number on the platform.
Full compound index with evidence tiers: peptidex.ai/compounds
*This content is for educational and informational purposes only. Not medical advice. See full Research Disclaimer.*
We email you when the FDA or HHS makes a move on a peptide you care about. Every email links the official source. No spam, no sales.
We don't collect health information. Unsubscribe anytime. Privacy policy